Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 1:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 1,820 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Overweight
Interventions: Weight loss; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 50 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Knee Cartilage Defects
Interventions: CARTISTEM® + Debridement, Debridement; Biological · Procedure
Lead sponsor: Medipost, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 37
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tempe, Arizona + 30 more

Conditions: Covid19, Risk Reduction, Stress, Sleep
Interventions: Hiking challenge, Activity list; Behavioral · Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Dengue
Interventions: Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC); Biological
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 45 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Colorectal Cancer
Interventions: Median Ranked Cancer Screening Messaging, Overall Preferred Cancer Screening Messaging, Black American Preferred Cancer Screening Messaging, White American Preferred Cancer Screening Messaging, Control; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 45 Years to 75 Years
Enrollment: 2,030 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Otitis Media
Interventions: telithromycin (HMR3647); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 6 Months to 59 Months
Enrollment: 639 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Age-related Cognitive Decline
Interventions: Delta-9-THC Low Dose, Placebo, Delta-9-THC Medium Dose; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Obesity
Interventions: Group Phone Calls, Social Media; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 21 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Fibrostenotic Crohn's Disease
Interventions: Ontunisertib, Placebo; Drug
Lead sponsor: Agomab Spain S.L.U.; Industry
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 7
States / cities: Sun City, Arizona • Bradenton, Florida • Albany, New York + 4 more

Conditions: Social Isolation, Loneliness
Interventions: Experimental Health Communication, Simulated Social Media Platform Only; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 29 Years
Enrollment: 1,900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Chronic Pain
Interventions: AtEase, Chronic Pain Education; Behavioral
Lead sponsor: Pro-Change Behavior Systems; Other
Eligibility: 18 Years and older
Enrollment: 268 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: West Haven, Connecticut • South Kingstown, Rhode Island

Conditions: Glioma
Interventions: Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging, Positron Emission Tomography; Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Otitis Media With Effusion, Acute Otitis Media, Otitis Media
Interventions: Iontophoresis and tube placement; Combination Product
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 6
States / cities: Louisville, Kentucky • Cherry Hill, New Jersey • New Brunswick, New Jersey + 3 more

Conditions: Immunoglobulin A Nephropathy, Glomerular Disease, IgAN
Interventions: Dose-Placebo, Low Dose-VIS649, Medium Dose-VIS649, High Dose-VIS649; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 17
States / cities: Birmingham, Alabama • Los Angeles, California • Oxnard, California + 13 more

Conditions: Media Effects on Literacy Gains in Young Children
Interventions: Media instruction, Storybook intervention; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 42 Months to 57 Months
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Acute Otitis Media
Interventions: Antipyrine and Benzocaine otic solution, Antipyrine Otic Solution, Benzocaine Otic Solution, Placebo Otic solution; Drug
Lead sponsor: Currax Pharmaceuticals; Industry
Eligibility: 2 Months to 12 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 10
States / cities: Mesa, Arizona • Tucson, Arizona • Bentonville, Arkansas + 5 more

Conditions: ALS
Interventions: Triheptanoin; Drug
Lead sponsor: Richard Bedlack, M.D., Ph.D.; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Abdominoplasty
Interventions: Abdominoplasty-Scarpa's fascia preservation, Abdominoplasty-Scarpa's fascia ablation, Lymphoscintigraphy, 3D Imaging, Abdominal ultrasound; Procedure · Device
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Varicose Veins
Interventions: Polidocanol Endovenous Microfoam (PEM); Drug
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Bradenton, Florida

Conditions: Stimulant Abuse, Criminal Behavior
Interventions: Decision task; Other
Lead sponsor: The Mind Research Network; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 334 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP), Pelvic Organ Prolapse Vaginal Surgery, Pelvic Organ Prolapse, Patient Education
Interventions: Postoperative Exercise regimen; Behavioral
Lead sponsor: NICHD Pelvic Floor Disorders Network; Network
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 7
States / cities: San Diego, California • Chicago, Illinois • Durham, North Carolina + 3 more

Conditions: Social Media, Adolescent Behavior
Interventions: Interactive Media Use Journal (IMUJ); Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 13 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Biological Markers, Diet, Healthy, Metabolomics, Nutrition, Healthy
Interventions: Pharmacokinetic (PK)- Controlled Feeding Diet, Dose Response (DR)- Controlled Feeding Diet; Other
Lead sponsor: Harvard School of Public Health (HSPH); Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Cardiovascular Diseases, Heart Diseases
Interventions: Tovinontrine (CRD-750), Placebo; Drug
Lead sponsor: Cardurion Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 557 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 26
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Beverly Hills, California + 23 more

Search by objective public record fields.

Effects of Medium Chain Triglyceride Oil, Versus Olive Oil, for Weight Loss

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

The Get Outside Study

Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain

Social Media and Cancer Screening Information

Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

Acute Effects of THC in Older Adult

Remote Delivery of Weight Management by Phone and Social Media

NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease

Keep Social Study for Young Adults

Evidence-based Pain Intervention for Veterans: AtEase for Chronic Pain

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry

Safety and Efficacy Study of VIS649 for IgA Nephropathy

Literacy Instruction Through Media for Everyone

Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media

A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)

Role of Preservation of Scarpa's Fascia in Abdominoplasty

Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Accelerometer Measured Early Recovery After Prolapse Surgery

Testing and Evaluating an Interactive Media Use Journal for Adolescents

Dietary Biomarkers Intervention Core

A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)